| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |